| Ruston Eye & Vision | |
|
2314 Common Ct Ste 2-3, Ruston, LA 71270-7225 | |
| (318) 232-6552 | |
| (318) 588-7930 |
| Full Name | Ruston Eye & Vision |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2314 Common Ct Ste 2-3, Ruston, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518478130 | NPI | - | NPPES |
| 2452118 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1857-791AT (Louisiana) | Primary |
| Provider Name | David Bradley Anders |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1023545910 PECOS PAC ID: 5092087916 Enrollment ID: I20170828000086 |
News Archive
The DASH eating plan, known to reduce blood pressure and bad cholesterol, also reduces the 10-year risk of heart attack, especially among African-Americans, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
The ability to engage in mental time travel - to delve back into past events or imagine future outcomes - is a unique and central part of the human experience. And yet this very ability can have detrimental consequences for both physical and mental well-being when it becomes repetitive and uncontrolled.
Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.
Pinpointing new targets for cancer treatments is as difficult as finding a needle in a haystack, yet a University of Rochester team has discovered an entire novel class of genes they believe will lead to a greater understanding of cancer cell function and the next generation of effective and less harmful therapies for patients.
A collaborative Brigham and Women's Hospital and Johns Hopkins University co-led team has found proof-of-concept evidence for a potential cancer treatment that leverages microparticles and mesenchymal stem cells.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruston Eye & Vision 2314 Common Ct Ste 2-3, Ruston, LA 71270-7225 Ph: (318) 232-6552 | Ruston Eye & Vision 2314 Common Ct Ste 2-3, Ruston, LA 71270-7225 Ph: (318) 232-6552 |
News Archive
The DASH eating plan, known to reduce blood pressure and bad cholesterol, also reduces the 10-year risk of heart attack, especially among African-Americans, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
The ability to engage in mental time travel - to delve back into past events or imagine future outcomes - is a unique and central part of the human experience. And yet this very ability can have detrimental consequences for both physical and mental well-being when it becomes repetitive and uncontrolled.
Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.
Pinpointing new targets for cancer treatments is as difficult as finding a needle in a haystack, yet a University of Rochester team has discovered an entire novel class of genes they believe will lead to a greater understanding of cancer cell function and the next generation of effective and less harmful therapies for patients.
A collaborative Brigham and Women's Hospital and Johns Hopkins University co-led team has found proof-of-concept evidence for a potential cancer treatment that leverages microparticles and mesenchymal stem cells.
› Verified 9 days ago
Dr. David Bradley Anders, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2314 Common Ct Ste 2-3, Ruston, LA 71270 Phone: 318-232-6552 Fax: 318-588-7930 | |
Dr. Edward G Gilcrease, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1010 S Vienna St, Ruston, LA 71270 Phone: 318-255-9433 Fax: 318-255-2425 | |
Dr. Jennifer Ann Floyd, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1010 S Vienna St, Ruston, LA 71270 Phone: 318-255-9433 | |
Dr. Gary James Avallone, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 911 Tech Drive, Ruston, LA 71270 Phone: 318-251-9095 Fax: 318-251-1705 | |
Northside Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 116 Killgore Rd, Suite 1, Ruston, LA 71270 Phone: 318-251-3626 Fax: 318-251-3330 | |
Anna Fuller Barbiero, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 116 Killgore Rd Ste 1, Ruston, LA 71270 Phone: 318-251-3626 |